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Several research lines are currently ongoing to address the multitude of facets of the pandemic COVID-19.
In line with the One-Health concept, extending the target of the studies to the animals which humans are
continuously interacting with may favor a better understanding of the SARS-CoV-2 biology and patho-
genetic mechanisms; thus, helping to adopt the most suitable containment measures. The last two de-
cades have already faced severe manifestations of the coronavirus infection in both humans and animals,
thus, circulating epitopes from previous outbreaks might confer partial protection from SARS-CoV-2
infections. In the present study, we provide an in-silico survey of the major nucleocapsid protein epi-
topes and compare them with the homologues of taxonomically-related coronaviruses with tropism for
animal species that are closely inter-related with the human beings population all over the world. Protein
sequence alignment provides evidence of high sequence homology for some of the investigated proteins.
Moreover, structural epitope mapping by homology modelling revealed a potential immunogenic value
also for specific sequences scoring a lower identity with SARS-CoV-2 nucleocapsid proteins. These evi-
dence provide a molecular structural rationale for a potential role in conferring protection from SARS-
CoV-2 infection and identifying potential candidates for the development of diagnostic tools and
prophylactic-oriented strategies.
© 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.As of 30 March 2020, SARS-CoV-2 diffusion becomes a world-
wide issue with nearly all countries of the globe being interested
in a steadily growing number of infected subjects and the ten-
dentially increasing mortality rate, by means of the COVID-19, in
the newly involved countries. On the other hand, the SARS-CoV-2
diffusion seems to be approaching an end in Wuhan, China, its
original epicentre. Here, the registration of new COVID-19 cases is
currently near zero, enabling the development of fair and unbiased
statistics on the COVID-19 data in the Hubei region [1,2]. The
thorough review of the patient cases describes, besides thee Europa, 88100, Catanzaro,
go San Vito n.1, 00168, Roma,
Urbani), roncada@unicz.it
vier Masson SAS. All rights reservecommon pulmonary issues, a wide variety of sequelae reported by
diverse patients from diverse hospitals following the viral infection.
These range from hearth injury until hepatic and kidney failure,
hindering a clear depiction of the pathogenetic mechanisms of the
novel virus and the definition of informative clinical signs patho-
gnomonic of SARS-CoV-2 infection [3,4]. Although the appropriate
consideration of the patient’s health status is of crucial importance
while assessing COVID-19 impact, it is believed that the severity of
COVID-19 depends on a plurality of factors that include, among
others, the load of viral particles transmitted between individuals,
the transmission route and the individual immune system effi-
ciency [5,6].
The causal agent of the current pandemic has been timely
classified as Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) [7]. In humans, coronavirus infections are commonly
manifested through weak clinical signs attributable to the seasonal
flu-like symptoms. Nevertheless, the last two decades have alreadyd.
Table 1
Selected virus overview. The table lists the viral specimens employed in this study
along with the relative details.
Virus NCBI
TaxID
NCBI Genome Protein GI
Bat CoV RaTG13 693998 MN996532 QHR63308.1
SARS-CoV 694009 NC_004718.3 AAX16200.1
Pangolin CoV 2708335 MT084071 NC_PangolinCoV
from [13]
Camel CoV 1335626 MK967708 QGV13487.1
MERS-CoV 1335626 NC_019843.3 YP_009047211.1
Dromedarius CoV 1335626 MH259486 QCI31487.1
H-Enteric CoV 166124 FJ415324 ACJ35489.1
Canine CoV 215681 KX432213 AQT26504.1
Bovine CoV 11128 NC_003045 NP_150083.1
Avian CoV 11120 NC_001451 NP_040838.1
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The first outbreak was described as the SARS epidemy registered in
2003 in China [8]; whereas a second coronavirus outbreak, known
as Middle East Respiratory Syndrome (MERS), dates back to 2012 in
Saudi Arabia. Besides humans [9], SARS viruses are able to infecting
a wide plethora of animals such as birds and mammals, including
synanthropic birds, dogs, camels, dromedaries, and pangolins [10].
SARS-CoV-2 is a member of the genus Betacoronavirus, featured by
a positive-sense, single-stranded RNA genome of approximately
30 Kbs. The viral genome encodes for a relatively low number of
proteins classified as either structural or nonstructural ones.
Among structural proteins, the spike glycoprotein (S), envelope
protein (E), membrane protein (M) and the nucleocapsid protein
(NC) are the major ones [7].
Nucleocapsid protein is a 50 KDa protein commonly involved in
the replication, transcription and packaging of the viral genome,
other than hindering the reproductive cycle of the host cell [11].
Also, NC is the most abundant protein in coronaviruses, is highly
immunogenic and its amino acid sequence is normally conserved,
making of this protein a suitable candidate target for both vaccine
formulations and diagnostic assays [12,13]. Previous studies on
SARS-CoV reported NC protein epitopes as capable of eliciting a
massive production of antibodies in infected subjects while its
prevalence was significantly reduced in convalescent patients,
suggesting such epitopes as candidates for the design of diagnostic
tools. Contrarywise, epitopes triggering T-cell response might
confer prolonged protection, in some cases estimated up to 11
years; thus, representing a valid alternative for the design of pro-
phylactic measures [14].
Acknowledged the recent identification of SARS-CoV-2, several
research lines are currently ongoing to address the multitude of
facets of this pandemic issue. Among these, defining the immu-
nological features of the SARS-CoV-2 might provide crucial
knowledge for the design of efficient diagnostic tools and/or vac-
cine strategy. In addition, comparing epitopes of taxonomically
related viruses can help to track an eventual cross-protection
occurring between humans and the domestic animals, meant as
the consequence of the continuous interrelation that, for various
reasons, occur among the diverse animal species.
In the present study, we provide an in-silico survey of the major
NC epitopes and compare them with the NC immunological do-
mains of taxonomically related coronaviruses with tropism for
synanthropic animal species that are closely inter-related with the
human beings population all over the world. Given the ongoing
status of the pandemic, both epitopes eliciting antibodies produc-
tion and T-cell responses will be taken into account, as even the
short-term antibody production can be protective for both human
and animals; thus, help to weaken the clinical manifestation of the
SARS-CoV-2 infection.2. Material and methods
2.1. Data collection
The virus species and accession number of the proteins
employed in this survey are provided in Table 1. Nucleocapsid
protein sequences were downloaded from the NCBI Protein re-
pository (https://www.ncbi.nlm.nih.gov/protein/) except for the
Pangolin nucleocapsid protein. The latter was obtained from the
recent publication of Zhang et al. (supplementary material: [13],
https://doi.org/10.1016/j.cub.2020.03.022) as no protein sequence
for the pangolin coronavirus was available at the time of the study.2.2. Computational processing of the protein sequences
The selected protein sequences were analyzed by using the Basic
Local Alignment Search Tool for protein sequences (pBLAST) [15].
This tool implements the BLOSUM62 algorithm to compare protein
sequences and calculates the statistical significance of matches as
means of e-values. Multiple sequence alignment was performed by
keeping default settings. Only the best hit for each coronavirus was
considered and hits with alignment length less than or equal to 4
amino acids were manually removed. Statistically significant
matches were employed for calculating the similarity tree of the
taxonomically-related coronaviruses on the basis of their relative
NC protein sequences. Fast minimum evolution algorithm was
employed to produce a tree from given distances between se-
quences by setting a maximum fraction of mismatch between pairs
of sequences of 0.85.
2.3. Structural mapping of epitopes to PDB structures
The mapped protein epitopes to SARS-CoV-2 NC protein
(YP_009724397.2 |P0DTC9) were alsomapped on two available PDB
structures using the PyMOL Molecular Graphics System, Version
2.3.4 (Schr€odinger, LLC.). Briefly, two NC 3D structure available in
the RCSB PDB database (6M3M and 2JW8, https://www.rcsb.org/)
covering respectively residues number 47e173 and 247e364 were
downloaded and mapping epitopes were visualized through
PyMOL. Distances between residues representing different se-
quences located on the surface of the 3D model were measured
using the wizard measurement to identify possible areas of cross-
reactivity and antigen-binding.
3. Results
The whole aminoacidic sequences of the nucleocapsid protein
from the selected coronavirus representatives were compared to
assess the similarity level existing between the conserved protein
sequences of the taxonomically related viruses. Fig. 1 depicts the
phylogenetic classification of the coronaviruses on the basis of their
NC protein. In this view, bat coronavirus RaTG13 is classified as the
most similar to the circulating SARS-CoV-2, followed by SARS-CoV
and the pangolin NC protein sequence. A separate clade is reserved
to MERS-CoV and the NC protein sequences of the coronaviruses
with tropism for camels (Camelus bactrianus) and dromedaries
(Camelus dromedarius). Nucleocapsid proteins of bovine, canine and
human enteric coronaviruses are depicted as sister groups of a third
clade with lower similarity in relation to SARS-CoV-2; whereas, the
avian coronavirus cluster apart since featured by the lowest simi-
larity with the circulating SARS-CoV-2. Phylogenetic classification
Fig. 1. Phylogenetic classification of the selected coronaviruses according to the whole nucleocapsid protein sequence homology.
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supported by the multiple sequence alignment performed on the
whole protein sequence. Here, NC from bat coronavirus RaTG13
shows a similarity with the SARS-CoV-2 homologue slightly above
99%. NC from SARS-CoV, instead, is approximately 90.3% similar
with the causal agent of COVID-19, followed by the NC sequence
from pangolin CoV with almost 88% sequence similarity. Other
selected coronavirus representatives have minor sequence simi-
larity as reported in Table 2.
Nucleocapsid protein sequences were further investigated for
the presence of major immunogenic sequences capable of eliciting
either antibodies production or eliciting T-cell response (Table 3)
according to the evidence reported in Ref. [14].
Epitopes falling within protein sequence domains for which
homology modelling based on the experimental crystallographic
structure is available are mapped and provided in Fig. 2 and Fig. 3;
whereas, the full list of the tested epitopes against the selected viral
nucleocapsid protein sequences is provided as Supplementary
material (S1).
Some of the mapped epitopes are “conserved” between the
circulating SARS-CoV-2, the SARS-CoV, bat RaTG13 CoV and the
pangolin CoV NC protein, i.e. the clade including the most similar
specimens; whereas, other epitopes are “shared” with a multitude
of coronavirus, including those from other animals that clustered as
dissimilar from the circulating SARS-CoV-2 (Fig. 1, Table 3 and
Table S1). With regard to interspecies distribution, all epitopes are
identified in the bat RaTG13 CoV and SARS-CoV, whilst the pangolinTable 2
Multiple sequence alignment of the Nucleocapside protein from taxonomically-related c
Virus Protein GI Identity (%)
Bat CoV QHR63308.1 99.045
SARS-CoV AAX16200.1 90.284
Pangolin CoV NC_PangolinCoV 87.857
Camel CoV QGV13487.1 48.492
MERS-CoV YP_009047211.1 48.492
Dromedarius CoV QCI31487.1 48.492
Bovine CoV NP_150083.1 38.938
H-Enteric CoV ACJ35489.1 38.348
Canine CoV AQT26504.1 38.348
Avian CoV NP_040838.1 29.664NC sequence fail to significatively align two of the epitope se-
quences classified as B-cells activating. In addition, epitopes
sequence comparison highlights that both bat RaTG13 coronavirus
and SARS-CoV scored 100% sequence identity with SARS-CoV-2
epitopes, whereas NC protein from pangolin results in a handful
of epitopes sharing a lower percentage of identity with the novel
2019 virus (Table 3 and Table S1).
Besides the most similar virus specimens, some epitope se-
quences are also identified in the viruses responsible for previous
coronavirus outbreaks and coronaviruses with tropism for synan-
thropic and domestic animals. Although identity percentage with
SARS-CoV-2 is below 100%, high homology levels have been scored
for MERS-CoV, camel-CoV, dromedary-CoV. Interestingly, bovine
CoV, canine CoV, human enteric CoV and avian-CoV have also
shared epitope sequences, despite the dissimilarity highlighted on
the basis of the whole NC sequence (Fig. 1, Table 3).
Structural mapping of the epitopes listed in Table 3 into two
high-fidelity 3D models of the NC protein domains (6M3M and
2JW8 entries of PDB database) shows that a plurality of epitopes is
mapped adjacent each other in a well define structural domain
which is defined by a radius of approximately 15 Å (Figs. 2 and 3).
Interestingly, these epitopes are coded in distal primary sequence
region of the NC protein which forms a conformational immuno-
genic domain (Figs. 2 and 3). Unfortunately, not all the investigated
epitopes can be mapped in the tridimensional model of the NC
protein due to the lack of confident model structure for the whole
protein length.oronaviruses.
Alignment length Mismatches e-value
419 4 e
422 38 e
420 8 e
398 179 7.14e-93
398 179 7.14e-93
398 179 9.55e-93
339 158 5.97e-54
339 160 1.98e-54
339 160 9.97e-54
327 210 2.00e-31
Table 3
Selected nucleocapsid protein epitopes.
Epitope Virus % Identity Length Alignment length Position e-value
KHWPQIAQ
FAPSASAFF
SARS-CoV 100 17 17 300e316 2.46e-16
Bat CoV 100 17 299e315 2.46e-16
Dromedarius CoV 78.571 14 293e306 7.55e-09
Camel CoV 78.571 14 293e306 7.55e-09
MERS-CoV 78.571 14 293e306 7.55e-09
H-Enteric CoV 52.941 17 308e324 7.05e-04
Canine CoV 52.941 17 308e324 7.05e-04
Bovine CoV 52.941 17 308e324 8.30e-05
Pangolin CoV 100 16 290e305 2.72e-16
AQFAPSA
SAFFGMSR
SARS-CoV 100 15 15 306e320 3.34e-13
Bat CoV 100 15 305e319 3.34e-13
Dromedarius CoV 71.429 14 297e310 2.75e-06
Camel CoV 71.429 14 297e310 2.75e-06
MERS-CoV 71.429 14 297e310 2.75e-06
H-Enteric CoV 63.636 11 314e324 0.001
Canine CoV 63.636 11 314e324 0.001
Avian CoV 58.333 12 276e286 13
Bovine CoV 63.636 11 314e324 1.73e-04
Pangolin CoV 100 15 295e309 3.33e-14
PKGFYAEG
SRGGSQASSR
SARS-CoV 100 18 18 169e186 2.32e-15
Bat CoV 100 18 168e185 2.32e-15
Dromedarius CoV 61.111 18 157e174 1.02e-04
Camel CoV 61.111 18 157e174 1.02e-04
MERS-CoV 61.111 18 157e174 1.02e-04
H-Enteric CoV 48 25 183e207 2.88e-04
Canine CoV 48 25 183e207 2.88e-04
Avian CoV 100 5 183e187 0.15
Bovine CoV 48 25 183e207 3.40e-05
Pangolin CoV 100 18 168e185 2.30e-16
QFAPSASAF
FGMSRIGM
SARS-CoV 100 17 17 307e323 6.91e-16
Bat CoV 100 17 306e322 6.91e-16
Dromedarius CoV 81.818 11 300e310 1.54e-05
Camel CoV 81.818 11 300e310 1.54e-05
MERS-CoV 81.818 11 300e310 1.54e-05
H-Enteric CoV 50 16 309e324 0.004
Canine CoV 50 16 309e324 0.004
Avian CoV 53.846 13 276e287 7.8
Bovine CoV 50 16 309e324 4.73e-04
Pangolin CoV 100 17 296e312 6.88e-17
QLPQGTTLPKGF
YAEGSRGGSQ
SARS-CoV 100 22 22 161e182 7.79e-20
Bat CoV 100 22 160e181 7.79e-20
H-Enteric CoV 66.667 15 177e191 3.16e-05
Canine CoV 66.667 15 177e191 3.16e-05
Dromedarius CoV 61.111 18 153e170 4.88e-04
Camel CoV 61.111 18 153e170 4.88e-04
MERS-CoV 61.111 18 153e170 4.88e-04
Avian CoV 100 5 183e187 0.22
Bovine CoV 66.667 15 177e191 3.72e-06
Pangolin CoV 100 22 160e181 7.75e-21
YNVTQAFGR
RGPEQTQGNF
SARS-CoV 100 19 19 269e287 4.02e-18
Bat CoV 100 19 268e286 4.02e-18
Dromedarius CoV 63.158 19 260e278 1.86e-06
Camel CoV 63.158 19 260e278 1.86e-06
MERS-CoV 63.158 19 260e278 1.86e-06
H-Enteric CoV 58.824 17 282e295 3.32e-04
Canine CoV 58.824 17 282e295 3.32e-04
Bovine CoV 58.824 17 282e295 3.91e-05
Pangolin CoV 100 15 261e275 2.40e-14
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The current health emergency raised by the COVID-19 aroused
the interest of the world-wide scientific community that actively
operates under diverse research lines on the attempt to address the
multiple facets of this pandemic issue, including the elucidation of
the immunological peculiarities of the novel virus.
The present study provides an in-silico survey of the major
epitope sequences of the nucleocapsid protein from taxonomically
related coronaviruses. Coronavirus infections and outbreaks were
already registered in the past decades in both humans and animals[8,9]. Thus, investigating whether immunological features of
taxonomically related viruses are shared with the SARS-CoV-2
might be helpful for planning innovative diagnostic and prophy-
lactic interventions. According to the One-Health approach,
defining the distribution of epitopes among viruses capable of
infecting synanthropic and/or domestic animals might represent a
key strategy for assessing the plausible occurrence of cross-
protection elicited by the continuous inter-relation existing be-
tween human and animal population. In this view, exposure to
epitopes from synanthropic animalsmight confer partial protection
from SARS-CoV-2 infection. This would explain, at least in part, the
Fig. 2. Epitope mapping into 6M3M structural model. The figure depicts mapping of the epitope sequence AQFAPSASAFFGMSR (yellow) and QFAPSASAFFGMSRIGM (cyan). A-panel
shows the surface mapping of the epitopes in the D structure of the nucleocapsid protein domain. B-panel highlights distances occurring between the mapped epitopes.
B. Tilocca et al. / Microbes and Infection 22 (2020) 188e194192early detection of class G immunoglobulins in newly infected
subjects and the big divergence occurring in the clinical manifes-
tation of the SARS-CoV-2 infections, other than preventing
epitopes-exposed subjects from the severe form of COVID-19 [16].
Nucleocapsid protein is a highly conserved protein involved in
the active phase of the viral infection. Being highly immunogenic is
commonly targeted in studies aimed at developing alternative
diagnostic tools and prophylactic strategies [11,14,17e19]. Multiple
alignments of the whole protein sequences highlight a very high
homology between the NC sequence of SARS-CoV-2 and bat
RaTG13 CoV.This evidence does not reflect the overall genome alignments
recently published where the draft whole-genome sequence of the
pangolin coronavirus is clustered as the closest relative to SARS-
CoV-2 [13]. Our outcomes, instead, highlight a closer functional
relationship between the bat RaTG13 and SARS-CoV-2 than the pair
pangolin CoV and SARS-CoV-2 when restricting the investigation to
a key structural protein. Also, NC protein of pangolin CoV fails to
align two epitope sequences, suggesting a separation between the
functional adaptation and molecular evolution. Moreover,
acknowledged the overall co-share of epitope sequences, the lack of
epitope alignments might be of importance for an accurate
Fig. 3. Epitope mapping into 2JW8 structural model. The figure depicts mapping of the epitope sequence PKGFYAEGSRGGSQASSR (blue), YNVTQAFGRRGPEQTQGNF (orange),
AQFAPSASAFFGMSR (green) and KHWPQIAQFAPSASAFF (red). A-panel shows the surface mapping of the epitopes in the D structure of the nucleocapsid protein domain. B- panel
highlights distances occurring between mapped epitopes.
B. Tilocca et al. / Microbes and Infection 22 (2020) 188e194 193elucidation of the role of pangolin as the intermediate host in the
virus life cycle.
With regard to epitopes distribution across viruses with tropism
for synanthropic and/or domestic animals, the survey highlights
that some epitope sequences are more “conserved” among the
most related specimens, while other epitopes are shared among a
wider ensemble of coronaviruses. Similar outcomes were also
described for the spike proteins epitopes [20]. In this view, a
detailed description of the epitopes distribution over the viral
population might provide valuable information driving future re-
searches aimed at setting efficient prophylactic strategies and/orthe design of tool capable of differential diagnosis on the basis of
serological tests.
The adjacent mapping of the tested epitopes in the tridimen-
sional models of the NC protein domains suggest the mapped area
as being highly immunogenic, exposed to the solvent and, conse-
quently, to molecular immune system effectors. Furthermore, this
supports the immunogenicity of the selected epitope sequences
which is of particular interest for that sequences scoring a lower
level of identity in relation to SARS-CoV-2 such as the canine CoV,
bovine CoV and the human enteric CoV. Although featured by a
lower level of homology with SARS-CoV-2 NC protein and the
B. Tilocca et al. / Microbes and Infection 22 (2020) 188e194194presence of some mismatches in the epitope sequence, these se-
quences are mapping in the same structural domains as SARS-CoV-
2 epitopes and are likely to be recognized by the host immune
system; thus, potentially involved in conferring partial protection
against SARS-CoV-2 infection other being considered good candi-
dates for the development of diagnostic tools and prophylactic-
oriented strategies.
To conclude, COVID-19 pandemic is a global issue that stimu-
lates the synergistic cooperation between research groups all over
the world. At the same manner, planning studies that seek to
address multiple aspects of COVID-19 enable a fast and effective
control of the SARS-CoV-2 infections. In line with the One-Health
concept, extending the target of the studies to the environment
and the animals which humans are continuously interacting with
favor a better understanding of this complex phenomenon and help
to adopt the most suitable containment measures. Continuing
mapping the major epitopes known for the viral proteins is, in our
view, a promising strategy. In this light, defining the map of the
circulating epitopes among diverse geographical areas and
considering the diverse people habits and animal population they
are interacting with might also provide unevaluable information
for the design of personalized prophylactic and diagnostic strate-
gies, shaped in dependence of the geographical context and the
subject’s habits. Thus, an incisive focus on these aspects can
contribute to a relatively fast control of this pandemic issue.
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